Skip to main content
Equibles

Twin Lakes Capital Management, LLC

Position in ATHE — Alterity Therapeutics Ltd

CIK 1847794 REDWOOD SHORES, CA
Back to ATHE Full portfolio

Position in ATHE

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$747,815
+$263,198 QoQ
Shares Held
139,258
0.0% QoQ
Ownership
0.765%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#1
of 21 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ATHE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Twin Lakes Capital Management, LLC holds $3,639,955 across 10 Biotechnology names. ATHE ranks #2 (20.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 20,000 $2,267,200
2 ATHE
Alterity Therapeutics Ltd
This page 		139,258 $747,815
3 JAZZ
Jazz Pharmaceuticals plc
 1,554 $374,467
4 REGN
Regeneron Pharmaceuticals, Inc.
 158 $98,519
5 MRNA
Moderna, Inc.
 1,231 $86,206
6 CRSP
CRISPR Therapeutics AG
 682 $37,196
7 VIR
Vir Biotechnology, Inc.
 2,195 $22,367
8 EDIT
Editas Medicine, Inc.
 1,250 $4,050

All Filings in ATHE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $747,815 139,258
2026-03-31 $484,617 139,258
2025-12-31 $428,914 139,258
2025-09-30 $523,610 139,258
2025-06-30 $24,233 5,925
2025-03-31 $20,441 5,925
2024-12-31 $19,611 5,925
2024-09-30 $7,761 5,925
2024-06-30 $10,724 5,925
2024-03-31 $12,264 5,925
2023-12-31 $14,753 5,925
2023-09-30 $14,694 5,925
2023-06-30 $16,530 5,925
2023-03-31 $16,471 5,925